Application of an epitope-based allocation system in pediatric kidney transplantation

Joshua Y. Kausman, Amanda M. Walker, Linda S. Cantwell, Catherine Quinlan, Matthew Sypek, Francesco L. Ierino

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Donor–recipient HLA mismatch remains a leading cause for sensitization and graft loss in kidney transplantation. HLA compatibility at an epitope level is emerging as an improved method of matching compared with current HLA antigen allocation. A novel epitope-based allocation approach to prospectively exclude donors with high-level mismatches was implemented for pediatric KTRs on the DD waiting list. Nineteen consecutive transplants were followed for 12 months, including eight DD KTRs listed with eplet exclusions, as well as three DD KTRs and eight LD KTRs without exclusions. KTRs with eplet exclusions had estimated GFR of 78.5 mL/min/1.73 m2, no episodes of rejection, and time to transplant 6.55 months. HLA-A, HLA-B, HLA-DR antigen mismatches were similar between all groups. KTRs with exclusions had significantly lower class II eplet mismatches (20.4) than the contemporary DD KTRs without exclusions (63.7) and DD KTRs transplanted in the preceding decade (46.9). dnDSAs were identified in two of eight DD KTRs with exclusions, two of three DD KTRs without exclusions and five of eight LD KTRs. Epitope-based allocation achieved timely access to transplantation, low class II eplet mismatches, and low rates of dnDSAs in the first year. This strategy requires longer follow-up and larger numbers, but has the potential to reduce anti-HLA sensitization and improve both graft survival and opportunities for future retransplantation.

LanguageEnglish
Pages931-938
Number of pages8
JournalPediatric Transplantation
Volume20
Issue number7
DOIs
Publication statusPublished - 1 Nov 2016
Externally publishedYes

Keywords

  • donor-specific antibody
  • epitope
  • kidney
  • pediatric
  • transplant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Kausman, J. Y., Walker, A. M., Cantwell, L. S., Quinlan, C., Sypek, M., & Ierino, F. L. (2016). Application of an epitope-based allocation system in pediatric kidney transplantation. Pediatric Transplantation, 20(7), 931-938. https://doi.org/10.1111/petr.12815
Kausman, Joshua Y. ; Walker, Amanda M. ; Cantwell, Linda S. ; Quinlan, Catherine ; Sypek, Matthew ; Ierino, Francesco L. / Application of an epitope-based allocation system in pediatric kidney transplantation. In: Pediatric Transplantation. 2016 ; Vol. 20, No. 7. pp. 931-938.
@article{cb14ca8316ff4cd5849ccb6b956af3b8,
title = "Application of an epitope-based allocation system in pediatric kidney transplantation",
abstract = "Donor–recipient HLA mismatch remains a leading cause for sensitization and graft loss in kidney transplantation. HLA compatibility at an epitope level is emerging as an improved method of matching compared with current HLA antigen allocation. A novel epitope-based allocation approach to prospectively exclude donors with high-level mismatches was implemented for pediatric KTRs on the DD waiting list. Nineteen consecutive transplants were followed for 12 months, including eight DD KTRs listed with eplet exclusions, as well as three DD KTRs and eight LD KTRs without exclusions. KTRs with eplet exclusions had estimated GFR of 78.5 mL/min/1.73 m2, no episodes of rejection, and time to transplant 6.55 months. HLA-A, HLA-B, HLA-DR antigen mismatches were similar between all groups. KTRs with exclusions had significantly lower class II eplet mismatches (20.4) than the contemporary DD KTRs without exclusions (63.7) and DD KTRs transplanted in the preceding decade (46.9). dnDSAs were identified in two of eight DD KTRs with exclusions, two of three DD KTRs without exclusions and five of eight LD KTRs. Epitope-based allocation achieved timely access to transplantation, low class II eplet mismatches, and low rates of dnDSAs in the first year. This strategy requires longer follow-up and larger numbers, but has the potential to reduce anti-HLA sensitization and improve both graft survival and opportunities for future retransplantation.",
keywords = "donor-specific antibody, epitope, kidney, pediatric, transplant",
author = "Kausman, {Joshua Y.} and Walker, {Amanda M.} and Cantwell, {Linda S.} and Catherine Quinlan and Matthew Sypek and Ierino, {Francesco L.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1111/petr.12815",
language = "English",
volume = "20",
pages = "931--938",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "7",

}

Kausman, JY, Walker, AM, Cantwell, LS, Quinlan, C, Sypek, M & Ierino, FL 2016, 'Application of an epitope-based allocation system in pediatric kidney transplantation', Pediatric Transplantation, vol. 20, no. 7, pp. 931-938. https://doi.org/10.1111/petr.12815

Application of an epitope-based allocation system in pediatric kidney transplantation. / Kausman, Joshua Y.; Walker, Amanda M.; Cantwell, Linda S.; Quinlan, Catherine; Sypek, Matthew; Ierino, Francesco L.

In: Pediatric Transplantation, Vol. 20, No. 7, 01.11.2016, p. 931-938.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Application of an epitope-based allocation system in pediatric kidney transplantation

AU - Kausman, Joshua Y.

AU - Walker, Amanda M.

AU - Cantwell, Linda S.

AU - Quinlan, Catherine

AU - Sypek, Matthew

AU - Ierino, Francesco L.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Donor–recipient HLA mismatch remains a leading cause for sensitization and graft loss in kidney transplantation. HLA compatibility at an epitope level is emerging as an improved method of matching compared with current HLA antigen allocation. A novel epitope-based allocation approach to prospectively exclude donors with high-level mismatches was implemented for pediatric KTRs on the DD waiting list. Nineteen consecutive transplants were followed for 12 months, including eight DD KTRs listed with eplet exclusions, as well as three DD KTRs and eight LD KTRs without exclusions. KTRs with eplet exclusions had estimated GFR of 78.5 mL/min/1.73 m2, no episodes of rejection, and time to transplant 6.55 months. HLA-A, HLA-B, HLA-DR antigen mismatches were similar between all groups. KTRs with exclusions had significantly lower class II eplet mismatches (20.4) than the contemporary DD KTRs without exclusions (63.7) and DD KTRs transplanted in the preceding decade (46.9). dnDSAs were identified in two of eight DD KTRs with exclusions, two of three DD KTRs without exclusions and five of eight LD KTRs. Epitope-based allocation achieved timely access to transplantation, low class II eplet mismatches, and low rates of dnDSAs in the first year. This strategy requires longer follow-up and larger numbers, but has the potential to reduce anti-HLA sensitization and improve both graft survival and opportunities for future retransplantation.

AB - Donor–recipient HLA mismatch remains a leading cause for sensitization and graft loss in kidney transplantation. HLA compatibility at an epitope level is emerging as an improved method of matching compared with current HLA antigen allocation. A novel epitope-based allocation approach to prospectively exclude donors with high-level mismatches was implemented for pediatric KTRs on the DD waiting list. Nineteen consecutive transplants were followed for 12 months, including eight DD KTRs listed with eplet exclusions, as well as three DD KTRs and eight LD KTRs without exclusions. KTRs with eplet exclusions had estimated GFR of 78.5 mL/min/1.73 m2, no episodes of rejection, and time to transplant 6.55 months. HLA-A, HLA-B, HLA-DR antigen mismatches were similar between all groups. KTRs with exclusions had significantly lower class II eplet mismatches (20.4) than the contemporary DD KTRs without exclusions (63.7) and DD KTRs transplanted in the preceding decade (46.9). dnDSAs were identified in two of eight DD KTRs with exclusions, two of three DD KTRs without exclusions and five of eight LD KTRs. Epitope-based allocation achieved timely access to transplantation, low class II eplet mismatches, and low rates of dnDSAs in the first year. This strategy requires longer follow-up and larger numbers, but has the potential to reduce anti-HLA sensitization and improve both graft survival and opportunities for future retransplantation.

KW - donor-specific antibody

KW - epitope

KW - kidney

KW - pediatric

KW - transplant

UR - http://www.scopus.com/inward/record.url?scp=84992426894&partnerID=8YFLogxK

U2 - 10.1111/petr.12815

DO - 10.1111/petr.12815

M3 - Article

VL - 20

SP - 931

EP - 938

JO - Pediatric Transplantation

T2 - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 7

ER -